Funding arb · Price arb / RWA
| Leg | Exchange | Price | Fund. /8h | Each payment | Next in | OI | Vol 24h | Lev | |
|---|---|---|---|---|---|---|---|---|---|
| LONG | 1,879.4 | +0.0050 | pay 0.0050% / 8h | 57m 57s | $934K | $1.8M | — | Long BingX | |
| SHORT | 1,876.8 | +0.0050 | get 0.0050% / 8h | 57m 57s | $9K | $109K | 10x | Short GRVT |
Price gap−0.141%108s
Funding gap0.0000% /8h
Funding is ≈ 0 and the gap is 0.156% under its 7d average: the price leg works against you, −$16 on $10k if it goes back.
If you open now and hold
on $10k a leg · figures of the last 7D, not a forecastFunding−$10.0000% /8h now · paid −0.011% over the last 7D
Price—spread −0.141%108s now · prices read too far apart to compare
Costsdoesn’t fit$10k a leg is deeper than the books hold
Result, before costs—+ Points / potential airdropGRVT: points · farm boardneeds both prices read together
Price and funding
1h · historyEntry / Exit
Price spread
Prices
Fundingper 8h
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now−0.141%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—
Where the spread has been, last 7D▾
share of time at each level
Funding on every exchange
/8hANTHROPIC on 26 exchanges
lowest funding firstBefore you open
2 ok · 4 to watch- Problem: Doesn’t fit the books—$10k a leg is deeper than GRVT’s order book right now.
- Note: Margin at max leverage— + $1,000BingX —, GRVT 10x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
- OK: Same payment interval8h / 8hBoth legs pay at the same time.Next 24h at the current rates, on $10k a leg: $0.00Long BingX: 3 payments, −$1.50; short GRVT: 3 payments, +$1.50.
- Watch: Prices read 108 s apart−0.141% vs +0.015%Part of this gap may be the market moving.
- Watch: Short leg is thinner$9K vs $934K OIGRVT sets your exit cost. Check its book before closing.
- OK: Points on a legGRVT pointsVolume here counts toward the points program.
- Watch: KYCBingX Yes · GRVT NoAdvanced KYC to deposit or trade; unverified accounts can only withdraw, up to 20,000 USDT a day. Rules vary by region.
Profit calculator
both legs, in and outPosition, each legHold forOrdersPrice spreadFunding rate
Funding earned−0.0005%/8h × 21 periods−$1.13
Price spreadprices read too far apart to compare—
Slippage, 4 ordersdoesn’t fit the book at $10k—
Fee BingX bp × 2 orders−$10.00
Fee GRVT bp × 2 orders−$9.00
Net · 7 days · $10k—
doesn’t fit the books at $10kprice spread not counted: prices read too far apartCosts to cover—Break-even—
Slippage: BingX: live order book, 14 min ago; GRVT: live order book, 40 min agoCost to enter
taker + slippage from mid, one sideBUY · LONGBingX0.0810.4 bp−$1019.9 bp−$199148.8 bp−$14.9K783.2 bp−$391.6K
SELL · SHORTGRVT2.67doesn’t fitdoesn’t fitdoesn’t fitdoesn’t fit
Closing costs about the same again.
| 10-26 14:52 | Markets by Kinetiq | Other | BREAKING: Anthropic filed its S-1 this morning. Nasdaq ticker: $ANT. On Markets, it jumped to $1,980.90 within five minutes of the filing on then fell to $1,856.80 in the next five. First-half revenue: $16.3B, up from $1.2B a year earlier. Priced in, or just getting started? @Markets_xyz on X ↗ |
| 10-26 14:32 | Entropy | Listing | Anthropic swung nearly 7% top to bottom in a single hour on Entropy after it filed its public S-1 to list on Nasdaq as ANT. Now at $1,888, implying $1.89T. @entropyIO on X ↗ |
| 10-26 14:21 | Kalshi | Other | JUST IN: Anthropic spent 80 pages of its S1 on AI risk factors, including a probable "human extinction" @Kalshi on X ↗ |
| 10-26 14:09 | tradeXYZ | Listing | The Pre-IPO Perpetual (IPOP) Market for Anthropic is now live. @tradexyz on X ↗ |
| 10-26 14:05 | Phoenix | Listing | Anthropic publicly files for its IPO, planning to list on Nasdaq under the ticker $ANT. $ANTHROPIC is trading at $1,896 on Phoenix, 24/7. @PhoenixTrade on X ↗ |
| 10-26 14:05 | Injective | Listing | The next major financial market for AI is the price of compute. Today, Injective is officially releasing the Super Intelligence Compute Index ($SICI), bringing a new financial primitive to the onchain AI economy. For the first time on Injective, traders can access a diversified index of @nvidia GPU rental prices through perpetuals with up to 10x leverage. We also plan to introduce a brand new financial primitive to access $SICI in the coming days. 🟪 A New Onchain Market for the Agentic Economy Trillions are set to be invested into AI infrastructure. From frontier model training to autonomous agents and inference, demand for compute is becoming one of the defining forces shaping the AI industry. This trend is only accelerating with giants like @OpenAI and @AnthropicAI surging in demand. Yet financial markets for compute remain largely underdeveloped, with rental prices fragmented across cloud providers and hardware generations. $SICI changes that. SICI brings five NVIDIA GPU rental rates together into a single onchain benchmark. The index consists of the following: → H100 (Industry standard for AI training): 40% → B200 (Next-generation AI training and inference): 25% → H200 (High-memory AI training and inference): 15% → A100 (Fine-tuning and AI inference): 10% → RTX 4090 (Consumer GPU for affordable AI inference): 10% Using hourly compute marketplace data, SICI creates a novel way to access and trade the economics of AI infrastructure. 🌏 Injective is building the onchain financial markets of tomorrow Injective pioneered the first onchain H100 rental market, launched the $AIX index, and introduced pre-IPO perpetuals for companies including OpenAI, @SpaceX and Anthropic. $SICI takes this vision further. First, Injective brought market exposure to the companies building the future of AI onchain. Now, we're bringing the cost of the infrastructure powering them onchain too. And we will soon be launching entirely new financial primitives to access the onchain agentic economy. The AI economy is creating entirely new asset classes. Injective is building the financial markets to access them for the first time onchain. @injective on X ↗ |


Kalshi
tradeXYZ
Phoenix
Injective